Patanjali and AIIMS Bhopal partner to develop holistic treatment solutions

AIIMS Bhopal has taken a historic step toward integrating Indian systems of medicine with modern healthcare through a Memorandum of Understanding (MoU) signed with the Patanjali Research Foundation Trust. This collaboration aims to promote joint research, education, and innovation by combining allopathic medical science with ancient Ayurvedic knowledge to offer comprehensive and effective healthcare solutions.

The MoU was signed in the presence of AIIMS Bhopal’s Executive Director, Prof. (Dr.) Ajai Singh, and Patanjali Research Institute’s Chief Scientist, Dr. Anurag Varshney. The partnership will focus on collaborative research in critical areas such as fatty liver disease, allergies, lifestyle-related disorders, liver ailments, respiratory issues, kidney diseases, and neurological disorders. A key point of discussion during the event was the clinical controlled trials of Patanjali’s evidence-based Ayurvedic medicines, Livogrit and Bronchom.

Prof. (Dr.) Ajai Singh highlighted that this agreement signifies a new chapter in healthcare, combining the strengths of modern medical science with traditional Indian knowledge to deliver more effective, accessible, and holistic treatment options. He also announced that the Patanjali Research Foundation Trust will establish the largest herbal garden in Madhya Pradesh within the AIIMS Bhopal campus, providing a valuable resource for research and academic pursuits.

Dr. Anurag Varshney credited the blessings of Param Pujya Swami Ramdev Ji and the inspiration of Param Shraddhey Acharya Balkrishna Ji for driving this collaboration, which he described as a significant move toward positioning Patanjali Ayurveda on the global stage.

Prof. (Dr.) Ashok Kumar, a key organizer of the event, called the initiative a milestone in India’s journey toward self-reliance and empowerment in medicine, emphasizing that it exemplifies the successful integration of modernity and ancient wisdom.

Also present at the event were AIIMS Bhopal’s Dean (Research) Prof. (Dr.) Rehan-UI-Haq, Dean (Academics) Prof. (Dr.) Rajnish Joshi, Prof. (Dr.) Ashok Kumar, and several other senior officials and scientists.

Related Posts

  • Pharma
  • July 15, 2025
  • 85 views
Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharmaceutical Industries Ltd has announced that it has entered into a settlement and license agreement with Incyte Corporation regarding litigation related to LEQSELVI (deuruxolitinib). “Under the terms of agreement,…

  • Pharma
  • July 15, 2025
  • 95 views
Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma on Tuesday said it will manufacture and supply the long-acting injectable HIV treatment cabotegravir across 133 countries. The Hyderabad-based drugmaker has been selected as one of the generic…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Aurobindo Pharma to manufacture, supply long acting HIV treatment drug

Famous Vaidyaratnam Ayurveda Clinic in Delhi is now more Accessible to Patients

Famous Vaidyaratnam  Ayurveda  Clinic in Delhi is now more Accessible to Patients

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR